Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Landscape Professional Research Report 2024
Description
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Landscape Professional Research Report 2024
Research Summary
Liposomal and lipid nanoparticle drug delivery systems are advanced drug delivery platforms that utilize liposomes or lipid nanoparticles to encapsulate and deliver drugs to specific target sites in the body. These systems have gained significant attention in recent years due to their ability to improve drug solubility, enhance drug stability, prolong drug circulation time, and increase drug accumulation at the target site.
Both liposomal and lipid nanoparticle drug delivery systems have been extensively studied and utilized in various therapeutic areas, including cancer, infectious diseases, inflammatory disorders, and genetic disorders. By encapsulating drugs within liposomes or lipid nanoparticles, these delivery systems can overcome various biological barriers, such as rapid drug clearance, poor drug solubility, and limited drug stability. Additionally, they can enhance drug accumulation at the target site, leading to improved therapeutic outcomes.
According to DIResearch's in-depth investigation and research, the global Liposomal and Lipid Nanoparticle Drug Delivery Systems market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Liposomal and Lipid Nanoparticle Drug Delivery Systems include Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma, Luye Pharma, Pacira, Leadiant Biosciences, Ipsen, Sayre Therapeutics, Jazz, Alnylam, Bausch Health, Acrotech Biopharma, Takeda, Chiesi Farmaceutici, Gilead Sciences etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Liposomal and Lipid Nanoparticle Drug Delivery Systems. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Liposomal and Lipid Nanoparticle Drug Delivery Systems market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Liposomal and Lipid Nanoparticle Drug Delivery Systems market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liposomal and Lipid Nanoparticle Drug Delivery Systems industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Liposomal and Lipid Nanoparticle Drug Delivery Systems Include:
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Luye Pharma
Pacira
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Segment Include:
Liposomes Drugs
Lipid Nanoparticle Drugs
Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Application Include:
Hospital
Retail Pharmacy
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Industry PESTEL Analysis
Chapter 3: Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Industry Porter’s Five Forces Analysis
Chapter 4: Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Regional Market Size and Forecast Analysis
Chapter 5: Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Liposomal and Lipid Nanoparticle Drug Delivery Systems Product by Type
- 1.2.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Liposomes Drugs
- 1.2.3 Lipid Nanoparticle Drugs
- 1.3 Liposomal and Lipid Nanoparticle Drug Delivery Systems Product by Application
- 1.3.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Hospital
- 1.3.3 Retail Pharmacy
- 1.3.4 Other
- 1.4 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Revenue Analysis (2019-2030)
- 1.5 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Development Status and Trends
- 1.5.1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Industry Development Status Analysis
- 1.5.2 Liposomal and Lipid Nanoparticle Drug Delivery Systems Industry Development Trends Analysis
- 2 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Analysis by Regions
- 4.1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Forecast by Region (2025-2030)
- 5 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type and Application
- 5.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type
- 5.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application
- 6 North America
- 6.1 North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type
- 6.4 North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application
- 6.5 North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type
- 7.4 Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application
- 7.5 Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type
- 8.4 China Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type
- 9.4 APAC (excl. China) Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application
- 9.5 APAC (excl. China) Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type
- 10.4 Latin America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application
- 10.5 Latin America Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Type
- 11.4 Middle East & Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Application
- 11.5 Middle East & Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Johnson & Johnson
- 13.1.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Johnson & Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.1.3 Johnson & Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Sun Pharmaceutical
- 13.2.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.2.3 Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 CSPC
- 13.3.1 CSPC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.3.3 CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Kinyond
- 13.4.1 Kinyond Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.4.3 Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Teva
- 13.5.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.5.3 Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Fudan-Zhangjiang
- 13.6.1 Fudan-Zhangjiang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.6.3 Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Zydus Cadila
- 13.7.1 Zydus Cadila Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.7.3 Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 TTY Biopharma
- 13.8.1 TTY Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.8.3 TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Luye Pharma
- 13.9.1 Luye Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.9.3 Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Pacira
- 13.10.1 Pacira Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.10.3 Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Leadiant Biosciences
- 13.11.1 Leadiant Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.11.3 Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.12 Ipsen
- 13.12.1 Ipsen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.12.3 Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.13 Sayre Therapeutics
- 13.13.1 Sayre Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.13.3 Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.14 Jazz
- 13.14.1 Jazz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.14.3 Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.15 Alnylam
- 13.15.1 Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.15.3 Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.16 Bausch Health
- 13.16.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.16.3 Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.17 Acrotech Biopharma
- 13.17.1 Acrotech Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.17.3 Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.18 Takeda
- 13.18.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.18.3 Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.19 Chiesi Farmaceutici
- 13.19.1 Chiesi Farmaceutici Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.19.2 Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.19.3 Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.20 Gilead Sciences
- 13.20.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.20.2 Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Portfolio
- 13.20.3 Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Industry Chain Analysis
- 14.2 Liposomal and Lipid Nanoparticle Drug Delivery Systems Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Liposomal and Lipid Nanoparticle Drug Delivery Systems Typical Downstream Customers
- 14.4 Liposomal and Lipid Nanoparticle Drug Delivery Systems Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
